Izabela G. Barbosa

Dec 4, 2024 | tandfonline.com | Izabela G. Barbosa |Aline Miranda |Michael Berk |Antonio L Teixeira

ABSTRACTIntroduction There is a growing body of evidence implicating gut-brain axis dysfunction in the pathophysiology of mood disorders. Accordingly, gut microbiota has become a promising target for the development of biomarkers and novel therapeutics for bipolar and depressive disorders. Areas covered We describe the observed changes in the gut microbiota of patients with mood disorders and discuss the available studies assessing microbiota-based strategies for their treatment.